ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

NCI To Fund 3,232, Research Project Grants In Fiscal 1993

January 15, 1993

NCI To Fund Approximately 850 Competing Grants In Fiscal 1986 Under Latest Budget Projections

February 28, 1986

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976

Beta Carotene Doesn’t Help, May Hurt, Two Trials Find

January 26, 1996

Senate Commitee Approves $1.058 Trillion To Reverse Sequestration Cuts

June 21, 2013